SMTL ID : 4ys7.2 (2 other biounits)

Co-crystal structure of 2-[2-(5,8-dimethyl[1,2,4]triazolo[1,5-a]pyrazin-2-yl)ethyl]-3-methyl-3H-imidazo[4,5-f]quinoline (compound 39) with PDE10A

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 5 residues within 4Å: Chain A: H.82, H.116, D.117, D.227 Ligands: MG.2 5 PLIP interactions: 4 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:H.82, A:H.116, A:D.117, A:D.227, H2O.1

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 4 residues within 4Å: Chain A: D.117, E.145, H.148 Ligands: ZN.1 5 PLIP interactions: 1 interactions with chain A, 4 Ligand-Water interactions Metal complexes: A:D.117, H2O.1, H2O.1, H2O.1, H2O.1

1 x 4GK: 2-[2-(5,8-dimethyl[1,2,4]triazolo[1,5-a]pyrazin-2-yl)ethyl]-3-methyl-3H-imidazo[4,5-f]quinoline(Non-covalent)

4GK.3: 11 residues within 4Å: Chain A: L.228, V.231, I.245, Y.246, F.249, P.265, M.266, E.274, G.278, Q.279, F.282 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.231, A:I.245, A:Y.246, A:F.249, A:M.266, A:F.282, A:F.282 Hydrogen bonds: A:Q.279 pi-Stacking: A:F.282, A:F.282

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Burdi, D.F. et al., Evolution and synthesis of novel orally bioavailable inhibitors of PDE10A. Bioorg.Med.Chem.Lett. (2015)

Release Date

2015-04-29

Peptides

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A

Related Entries With Identical Sequence